2nd Quarter - Report

HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) for BOEHRINGER INGELHEM PHARAMACEUTICALS INC

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Compounding pharmacy legislation, drug safety, drug patents, federal health care spending

LobbyistCovered position, as disclosed
CHARLES M. CLAPTON New Health Policy Dir, Senate HELP Cmte

Contacted: HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.